Biosimilar Pricing and Competition: How Political Visibility Shapes Biologic Pricing after Loss of Exclusivity Introduction Biologics have reshaped the treatment landscape across a broad Read More »
Navigate access policies European Hospital Exemption Pathways for ATMPs : Implementation and Impact Read More
Navigate access policies Using the Hospital Exemption Pathway to improve patient access to ATMPs in Europe Read More
Navigate access policies How should pharmaceutical companies prepare for the upcoming joint EU HTA? Read More
Navigate access policies Four Market Access Measures Triggered by COVID-19 That Are Here To Stay Read More
Navigate access policies Reflections on The Initial Impact of COVID-19 on Global Market Access Activities Read More
